Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Global Payments Completes Acquisition of Worldpay and Divestiture of Issuer Solutions Business, Creating Leading Pure-Play Commerce Solutions Provider
-
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
-
Palladyne AI Announces Commercial Availability of Palladyne IQ 2.0, Delivering Industrial Autonomy to Accelerate Defense-Industrial Modernization, Agility, and Throughput
-
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
-
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
-
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
-
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
-
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
-
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
-
FIS Completes Strategic Acquisition of Global Payments’ Issuer Solutions Business and Sale of Worldpay Stake
-
AZIO receives $100 Million worth of Government Purchase Orders, Advances $200 Million Regional Pipeline and Scalable U.S. AI Infrastructure Expansion
-
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
-
Sable Announces Director Change
-
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
-
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
-
Utz Brands, Inc. Announces Preliminary Fourth Quarter and Fiscal Year 2025 Results
-
LiquiDonate Releases 2026 Returns Fraud Report
-
Shake Shack Provides Fiscal Fourth Quarter 2025 Business Update
-
WindRose Health Investors Makes Investment in Avalon Healthcare Solutions
-
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
-
SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer
-
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
-
Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion
-
Aeva to Participate in the 28th Annual Needham Growth Conference
-
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Northwestern Medicine Selects Tempus to Expand Genomic Testing
-
Vince Holding Corp. Provides Holiday Sales Results
-
Coppernico Defines 155 m of Continuous Copper Mineralization Averaging 0.54% at Sombrero’s Nioc Target
-
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis
-
SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
-
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
-
Subaru Selects Dynamic Map Platform’s HD Map Data for New Advanced EyeSight® Driver Assist Technology
-
Everseen Unveils Everact: The First Agentic AI Platform for Conversational Retail Intelligence
-
Mobileye Announces Timing of its Fourth Quarter and Full Year 2025 Results
-
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
-
K Wave Media Leads Investment in “Once We Were Us,” Now the #1 Film at the Korean Box Office
-
Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator
-
Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
-
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
-
Surge Copper Appoints Jennifer Anthony as Vice President, Environment and Regulatory Affairs
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue
-
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
-
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
-
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
-
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
-
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
-
NewtekOne, Inc. Announces Extension of Exchange Offer for its Notes due 2026
-
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
-
KEY Investment Partners Acquires BellRock Brands’ Portfolio, Home of Mary’s Medicinals, Dixie and Other Top Names
-
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
